The conversion of 2-chloro-cis,cis-muconate by muconate cycloisomerase from Pseudomonas putida PRS2000 yielded two products which by nuclear magnetic resonance spectroscopy were identified as 2-chloro-and 5-chloromuconolactone. High-pressure liquid chromatography analyses showed the same compounds to be formed also by muconate cycloisomerases from Acinetobacter calcoaceticus ADP1 and Pseudomonas sp. strain B13. During 2-chloro-cis,cis-muconate turnover by the enzyme from P. putida, 2-chloromuconolactone initially was the major product. After prolonged incubation, however, 5-chloromuconolactone dominated in the resulting equilibrium. In contrast to previous assumptions, both chloromuconolactones were found to be stable at physiological pH. Since the chloromuconate cycloisomerases of Pseudomonas sp. strain B13 and Akaligenes eutrophus JMP134 have been shown previously to produce the trans-dienelactone (trans4-carboxymethylenebut-2-en-4-olide) from 2-chloro-cis,cis-muconate, they must have evolved the capability to cleave the carbonchlorine bond during their divergence from normal muconate cycloisomerases.
The bacterial mineralization of chloroaromatic compounds necessarily involves the cleavage of carbon-chlorine bonds, liberating inorganic chloride. In several cases, this is achieved prior to the opening of the aromatic ring by reductive, oxygenolytic, or hydrolytic reactions (for reviews, see references 12, 19, and 45) . In many other cases, however, chloride elimination occurs only after ring cleavage has been accomplished. Corresponding catabolic pathways have been described mainly for mono-and dichlorosubstituted phenoxyacetates, phenols, benzoates, benzenes, anilines, salicylates, and metabolic precursors of them. Under aerobic conditions, all of these compounds are usually first converted to chlorocatechols as central intermediates. These are then subject to intradiol (ortho) ring cleavage, giving rise to chlorosubstituted cis,cismuconates. It has long been known (3, 13, 14, 57) that chloride elimination on this pathway is related to the conversion of mono-and dichloromuconates to unsubstituted or chlorosubstituted dienelactones (4-carboxymethylenebut-2-en-4-olides) (Fig. 1) . The dienelactones are then cleaved hydrolytically, and the products are finally funneled into the 3-oxoadipate pathway (10, 13, 14, 24, 48, 52, 57, 60) .
Bacteria, employing the modified ortho cleavage pathway outlined above, usually do so by inducing a set of plasmidencoded enzymes which are specially adapted for the turnover of chlorocatechols or their respective metabolites (9, 41, 48) . With the exception of maleylacetate reductase, these enzymes catalyze reactions analogous to those of the ordinary 3-oxoadipate pathway.
Muconate cycloisomerase (EC 5.5.1.1) and chloromuconate cycloisomerase (EC 5.5.1.7) were first differentiated by Schmidt and Knackmuss (48) in the 3-chlorobenzoate-utilizing strain Pseudomonas sp. strain B13. The authors reported that both enzymes catalyze basically the same reactions and that they differ only with respect to their substrate specificity, the chloromuconate cycloisomerase having higher activities and affinities for substituted cis,cis-muconates than the normal muconate cycloisomerase. Schmidt and Knackmuss correspondingly assumed that, for both cycloisomerases, only the conversion of 2-chloromuconate and 3-chloromuconate to 5 -chloromuconolactone (4-carboxychloromethylbut-2-en-4-olide) and 4-chloromuconolactone (4-carboxymethyl-4-chlorobut-2-en-4-olide), respectively, is enzyme catalyzed, while chloride elimination from these intermediates was regarded as a spontaneous, nonenzymatic reaction ( Fig. 2A) .
Doubts as to the validity of this conclusion arose when a methylsubstituted 5-chloromuconolactone turned out to be stable under physiological conditions ( Fig. 2B) (42) . We now show that the normal muconate cycloisomerases of Acinetobacter calcoaceticus ADP1, Pseudomonas putida PRS2000, and Pseudomonas sp. strain B13 convert 2-chloro-cis,cis-muconate to a mixture of 2-chloro-and 5-chloromuconolactone. This contrasts with trans-dienelactone being the product of 2-chloromuconate turnover by chloromuconate cycloisomerases (28, 48) , and it implies that the latter enzymes, during their evolution from normal muconate cycloisomerases, had to acquire the capability to dehalogenate. Some of the results have been reported recently in a preliminary communication (59 For the purification of muconate cycloisomerase from A. calcoaceticus ADP1, 380 ml of cell extract (total activity, 2,970 U; protein, 4.6 g; specific activity, 0.65 U/mg) was applied to a Q Sepharose Fast Flow column (BP 113/30; column volume, 1.45 liter) equilibrated with 50 mM Tris-HCl (pH 7.5). Elution was performed with a linear NaCl gradient from 0 to 0.5 M NaCl over 10 liters (flow rate, 80 ml/min; fraction volume, 250 ml). Muconate cycloisomerase eluted at 0.25 M NaCl (total activity, 2,320 U). From the fractions with muconate cycloisomerase activity (750 ml), protein was precipitated with (NH4)2SO4 (75% saturation) and resuspended in 35 ml of 50 mM Tris-HCl (pH 7.5)-l mM MnSO4-0.1 M NaCl. The preparation was then subjected to gel filtration on a Sephacryl S 200 column (XK 50/100; volume, 2 liters; length, 1 m), using the same buffer for elution. Muconate cycloisomerase activity eluted at 680 ml (flow rate, 6 ml/min; fraction volume, 20 ml). The resulting enzyme solution (100 ml; total activity, 850 U; specific activity, 41.2 U/mg) was concentrated to a volume of 6 ml and partially desalted by using Amicon PM10 filters and repeated dilution with 50 mM Tris-HCl (pH 7.5)-i mM MnSO4. As a final purification step, the concentrate was applied to a Mono Q HR 5/5 column equilibrated with the same buffer. A gradient from 0 to 0.5 M NaCl over 30 ml was employed for elution (flow rate, 1 ml/min; fraction volume, 1 ml). The resulting preparation had total and specific activities of 108 U and 77 U/mg, respectively. On a sodium dodecyl sulfate (SDS)-polyacrylamide gel, one broad band and two additional small bands (less than 5%) were visible after silver stain.
The Pseudomonas sp. strain B13 muconate cycloisomerase was purified by the following procedure (see also Table 3 ). The cell extract was applied to a Mono Q HR 5/5 column which had been equilibrated with 20 mM Tris-HCl (pH 7.5)-0.5 mM MnSO4. Elution was achieved with a linear gradient from 0 to 0.5 M NaCl over 75 column volumes (flow rate, 0.8 ml/min; fraction size, 1 ml; two parallel runs). Muconate cycloisomerase eluted at 0.17 M NaCl. After the addition of 1 M (NH4)2SO4 to the fractions with muconate cycloisomerase activity, the fractions were chromatographed on a Phenyl Superose HR 10/10 column which had been equilibrated with 50 mM Tris-HCl (pH 7.5)-0.5 mM MnSO4-1 M (NH4)2SO4. A decreasing gradient of (NH4)2SO4 (1 to 0 M over 21 column volumes) resulted in elution of muconate cycloisomerase at 0.57 M (NH4)2SO4 (flow rate, 1 ml/min; fraction size, 3 ml).
The preparation was concentrated by using Amicon Centricon 10 microconcentrators and then subjected to gel filtration on a Superdex 200 prep-grade column (HiLoad 16/60; column volume, 120 ml; bed length, 60 cm; flow rate, 0.7 ml/min; fraction size, 1 ml) by using 50 mM Tris-HCl (pH 7.5)-0.1 mM MnSO4-0.1 M NaCl for elution.
Electrophoretic methods. Discontinuous SDS electrophoresis was performed on 0.5-mm-thick vertical slab gels of 7-cm length by a modification of the Laemmli (29) procedure. The acrylamide concentrations were 5 and 10% (wt/vol) for the concentrating and the separating gels, respectively. Electrophoresis proceeded at 200 V for 1 h at 4°C. The proteins were stained by a modification of the procedure of Merril et al. (30) , using the Bio-Rad silver staining kit.
Analytical HPLC. Quantitative analyses of low-molecularweight compounds were performed by reversed-phase highpressure liquid chromatography (HPLC) with a Grom SIL 100 C8 reversed-phase column (length, 250 mm; internal diameter, 4.6 mm; Grom, Herrenberg, Germany). Methanol-H20 (40: 60) containing 0.1% (wt/vol) H3PO4 was used as the solvent at a flow rate of 0.6 ml/min. Detection was performed at 210 nm. Typical retention volumes were as follows: maleylacetic acid, 2.91 ml; cis-acetylacrylic acid acylale, 3.02 ml; 5-chloromuconolactone (compound II), 3.13 ml; trans-dienelactone, 3.49 ml; trans-acetylacrylic acid, 3.66 ml; 2-chloromuconolactone (compound I), 3.72 ml; cis-dienelactone, 4.38 ml; protoanemonin, 4.67 ml; 2-chloro-cis,cis-muconic acid, 5.57 ml; 2-chloro-cis, trans-muconic acid, 5.87 ml.
Preparative conversion of 2-chloro-cis,cis-muconate to 5-chloro-and 2-chloromuconolactone. The reaction mixture initially contained the following components (total volume, 1 liter): 20 (49) . cis-Dienelactone (cis-4-carboxymethylenebut-2-en-4-olide) was generously provided by G. W. Ashley (Evanston, Ill.), and trans-dienelactone (trans-4-carboxymethylenebut-2-en-4-olide) was available from a previous synthesis (44) . Maleylacetate was prepared from cis-dienelactone by alkaline hydrolysis (14) . Protoanemonin was synthesized from transacetylacrylic acid as published by Shaw (53) . cis,cis-Muconic acid and (+)-muconolactone were generously provided by K.-L. Ngai and L. N. Ornston (New Haven, Conn.). 3-Oxoadipate enol-lactone hydrolase, needed as an auxiliary enzyme, was purified from an extract of benzoate-grown cells of P. putida PRS2000 in our group by using a combination of hydrophobic interaction, anion-exchange, and gel filtration chromatographies. Partially purified dienelactone hydrolase of A. eutrophus JMP134 was obtained as a by-product of chloromuconate cycloisomerase purification, performed in a similar way as reported previously (20) .
RESULTS
Preliminary experiments on the conversion of 2-chlorocis,cis-muconate. When analyzing the substrate specificity of purified muconate cycloisomerases from P. putida PRS2000 and A. calcoaceticus ADP1, 2-chloro-cis,cis-muconate was observed to be converted to products that were not substrates for the dienelactone hydrolase of A. eutrophus JMP134. This was contradictory to the results of Schmidt and Knackmuss (48) , who reported that 2-chloro-cis,cis-muconate was converted to trans-dienelactone by both chloromuconate cycloisomerase and muconate cycloisomerase of Pseudomonas sp. strain B13. Repeated UV spectra during turnover of 2-chloro-cis,cismuconate by muconate cycloisomerases of P. putida PRS2000 and A. calcoaceticus ADP1 showed, however, a decrease in A266 without a concomitant increase of A277, the maximum of absorption of dienelactones (48) (Fig. 3) . Furthermore, HPLC analyses, including in situ UV spectra, revealed that two compounds were formed and that some of the 2-chloro-cis,cismuconate was not converted. Compound I showed a retention volume of 3.72 ml and a maximum of UV absorption at 220 nm, which was in agreement with values obtained for chemically synthesized 2-chloromuconolactone. For compound II, a retention volume of 3.13 ml and a maximum of UV absorption at 205 nm were determined, but none of the available standards showed similar characteristics. Retention volumes and maxima of UV absorption definitely excluded an identification of compound I or II as trans-dienelactone (retention volume, 3.49 ml). The UV data rather implied that both products should not have a system of conjugated double bonds as that in muconic acid or dienelactone structures. Therefore, the possibility was considered that compound II could be 5-chloromuconolactone because one possible direction of cycloisomerization (1,4-cycloisomerization) of 2-chloro-cis,cis-muconate results in 2-chloromuconolactone, while the alternative direction (3,6-cycloisomerization) yields 5-chloromuconolactone (Fig. 4) . chloro-cis,cis-muconate was subjected to turnover by purified P. putida PRS2000 muconate cycloisomerase. After several hours, the reaction medium was acidified, and the mixture was extracted with ethyl acetate. From the extract, compounds I and II were isolated by preparative HPLC, followed by another extraction. After evaporation of the solvent, both compounds were obtained as yellow oils which could be crystallized by freeze-drying. The yields were 123 mg for compound I and 47 mg for compound II.
The 1H NMR spectrum of compound I (Table 1) shows one olefinic proton at 7.799 ppm, a chemical-shift value typical for the P-proton in an o,I-unsaturated carbonyl system. The characteristic AB spectrum for two methylene protons at 2.834 and 2.983 ppm is indicative of a CH2 group close to a stereogenic center (asymmetric carbon atom). A methine proton at 5.505 ppm is coupled to both the olefinic and the two CH2 protons (Table 1) . Thus, the olefinic, the methine, and the methylene protons must be bonded to adjacent carbon atoms, i.e., C-3, -4, and -5 of the muconolactone skeleton. The individual chemical shifts are in good agreement with the data given by Schmidt et al. (49) for 2-chloromuconolactone (4-carboxymethyl-2-chlorobut-2-en-4-olide). An independent proof for this structural assignment comes from the 13C NMR data ( Table 1) .
The 1H NMR spectrum of compound II ( only one stereogenic center at C-4 (asymmetric carbon atom) and was shown to be optically active, the addition to the double bond must have been highly stereoselective and therefore presumably enzyme catalyzed. Assuming a syn addition in the same orientation as that for the conversion of cis,cis-muconate and 3-methyl-cis,cis-muconate to (4S)-muconolactone and (4S)-4-methylmuconolactone, respectively (2, 5, 27) , (+)-2-chloromuconolactone can be expected to have a 4S configuration (Fig. 4) . 5-Chloromuconolactone has two asymmetric carbon atoms, and therefore, as in the case of 5-chloro-3-methylmuconolactone (42), two diastereomers should be formed, if cycloisomerization were nonenzymatic and acid catalyzed. However, neither HPLC analyses nor NMR spectra indicated the presence of a second diastereomer. In addition, the optical activity of the 5-chloromuconolactone preparation showed it not to be a racemic mixture. Since no other diastereomer or enantiomer was formed, 5-chloromuconolactone should also be the product of an enzymatic cycloisomerization. Assuming again a syn addition analogous to the reactions with cis,cis-muconate and 3-methyl-cis,cis-muconate, (+)-5-chloromuconolactone should have a 4S,5S configuration (Fig. 4) .
Stability of 5-chloro-and 2-chloromuconolactone. Schmidt and Knackmuss (48) . proposed that 5-chloromuconolactone would be an unstable intermediate of 2-chloro-cis,cis-muconate conversion, subject to spontaneous antielimination of HCl to give the trans-dienelactone. The isolation of 5-chloromuconolactone already refuted this assumption, but because of the relevance for the mechanism of dehalogenation, the stability of both isolated chloromuconolactones was investigated more closely (Table 2 ). Both 5-chloro-and 2-chloromuconolactone proved to be remarkably stable under acidic and neutral conditions. At pH 7.5, 5-chloromuconolactone had a half-life of 99 h, while that of 2-chloromuconolactone was 194 h. Only under alkaline conditions did the half-lives of these metabolites decrease significantly. 5-Chloromuconolactone at high pH was rapidly converted to trans-dienelactone, which was further hydrolyzed to maleylacetate, while the products of 2-chloromuconolactone conversion could not be identified.
Equilibrium between 2-chloro-cis,cis-muconate, 2-chloromuconolactone, and 5-chloromuconolactone. As shown previously (35, 54) , the conversion of unsubstituted muconate to muconolactone is fully reversible. This also seems to hold for the conversion of 2-chloro-cis,cis-muconate to the chlorosubstituted muconolactones by muconate cycloisomerases. The time course of the reaction at pH 7.0 revealed that at first 2-chloromuconolactone was the predominant product but that later an apparent equilibrium was reached in which a considerable amount of 2-chloro-cis,cis-muconate was left and 5-chloromuconolactone was present in higher concentrations than 2-chloromuconolactone (Fig. 5A) . Further HPLC analyses and overlay UV spectra showed that both 5-chloro-and 2-chlorpmuconolactone were also converted by muconate cycloisomerase to a mixture of 2-chloro-cis,cis-muconate and the chloromuconolactones (Fig. SB and C) . This clearly proves the reversibility of 2-chloro-cis,cis-muconate cycloisomerization. The equilibrium constants for 1,4-and 3,6-cycloisomerization, x 106, respectively. These values are smaller than that reported for the cis,cis-muconate-(+)-muconolactone equilibrium (35, 54) . The initial reaction rates for the formation of 2-chloromuconolactone and 5-chloromuconolactone from 2-chloro-cis,cis-muconate (initial concentrations, between 0.1 and 1 mM) were determined by HPLC to be 0.16 and 0.075 U/mg, respectively (measurements with the P. putida muconate cycloisomerase at pH 7.5). Thus, while the conversion to 2-chloromuconolactone is favored kinetically (at least in the case of the P. putida enzyme), 5-chloromuconolactone is the thermodynamically preferred product.
The equilibrium between 2-chloro-cis,cis-muconate, 5-chloromuconolactone, and 2-chloromuconolactone was dependent on pH (Fig. 6) . Acidic conditions favored the formation of the Table  3) . The turnover of 2-chloro-cis,cis-muconate by Pseudomonas sp. strain B13 muconate cycloisomerase gave changes in the UV spectra similar to those observed with the P. putida enzyme (Fig. 3) . HPLC analyses showed that, in the reaction mixture, two products appeared with the same retention volumes as 5-chloromuconolactone and 2-chloromuconolactone, respectively. Coinjection of authentic 5-chloro-and 2-chloromuconolactone with the reaction mixture resulted in coelution of the standards and the products formed by the strain B13 muconate cycloisomerase. No trans-dienelactone could be detected. We therefore conclude that the muconate cycloisomerase from Pseudomonas sp. strain B13 does not have the ability to dehalogenate 5-chloromuconolactone.
DISCUSSION
The pathways for chlorocatechol degradation, as found in a number of strains utilizing chloroaromatic compounds, involve three reactions which are chemically analogous to those of the catechol branch of the 3-oxoadipate pathway (Fig. 1) are in fact homologous to usual catechol 1,2-dioxygenases and muconate cycloisomerases (1, 11, 15-17, 25, 31, 38, 51, 58) . Chloromuconate cycloisomerases and muconate cycloisomerases have originally been differentiated principally by their substrate specificities (28, 48) , and for the two enzymes in Pseudomonas sp. strain B13, it has been reported that they catalyze the same reactions, only with different rates (48) . The evolution of the chloromuconate cycloisomerases from muconate cycloisomerases therefore seemed to have been mainly a question of appropriate changes of substrate specificities. For the conversion of 3-chloro-and 2,4-dichloromuconate by chloromuconate cycloisomerases, such changes could theoretically be sufficient. Assuming a similar reaction mechanism as that reported for the muconate cycloisomerase of P. putia (32, 33) , chloride could be hypothesized to be eliminated from an anionic intermediate (46) . If this were true, dehalogenation from 3-chloro-and 2,4-dichloromuconate would be a reaction catalyzed gratuitously by muconate and chloromuconate cycloisomerases.
In contrast, in the case of 2-chloromuconate cycloisomerization, chloride release could not be readily explained by a gratuitous elimination from an anionic intermediate. Consequently, as suggested by Schmidt and Knackmuss (48), 5-chloromuconolactone had to be assumed to be formed as an intermediate, yielding trans-dienelactone in a reaction originally claimed to be spontaneous (nonenzymatic). Recently, however, Pieper et al. (42) reported that 5-chloro-3-methylmuconolactone is stable under physiological conditions. Since the methylsubstituent could not be expected to have a major stabilizing effect on the carbon-chlorine bond, this observation raised questions as to the nonenzymatic character of chloride elimination from 5-chloromuconolactone.
In the present article, we show that muconate cycloisomerases, including the enzyme from Pseudomonas sp. strain B13, do not form the same product from 2-chloromuconate as the chloromuconate cylcoisomerases investigated previously. Instead of trans-dienelactone, a mixture of (+)-2-chloro-and (+)-5-chloromuconolactone was found to be produced. Spontaneous elimination of HCl does not occur at a significant rate at physiological pH. Therefore, during their evolution, chloromuconate cycloisomerases must have developed a mechanism to catalyze a dehalogenation. Thus, these enzymes differ from muconate cycloisomerases in more respects than an altered substrate specificity.
Schmidt and Knackmuss (48) might have been led to their erroneous conclusion because the work was not done with purified enzymes. Pieper et al. (43) reported that muconolactone isomerases catalyze the conversion of 5-chloro-3-methylmuconolactone (Fig. 2) to a 3-methyldienelactone (4-carboxymethylene-3-methylbut-2-en-4-olide), suggesting that these enzymes might also convert 5-chloromuconolactone to a dienelactone. We observed that 5-chloromuconolactone is indeed turned over by a preparation of partially purified muconolactone isomerase from A. calcoaceticus, giving rise to dienelactones as products (data not shown (48) . Thus, muconolactone isomerase, as an impurity in the muconate cycloisomerase preparation, is a likely reason for the formation of trans-dienelactone from 2-chloro-cis,cis-muconate which was noted by these authors.
From the present observations, it becomes obvious that the evolution of chloromuconate cycloisomerases from ordinary muconate cycloisomerases was not just a question of altered substrate specificities but that new catalytic capabilities had to be acquired. We expect that the available sequence information (1, 15, 17, 38, 51, 58) and especially the known structures of P. putida muconate cycloisomerase (18) and pJP4-encoded chloromuconate cycloisomerase (20, 22) will allow us in the near future to better understand the mechanism of dehalogenation and its evolution at the molecular level. 
